Medical/Pharmaceuticals
AI Proves Its Value in Assistance for Emergency Cases - With Higher Accuracy and Timely Reporting Time of Chest Radiographs
SEOUL, South Korea, Dec. 23, 2020 /PRNewswire/ -- A study conducted by Seoul National University Hospital, one of the most renowned medical institutes in Asia, has revealed that an AI can help radiologists improve their performance and reduce reporting time for critical or urgent cases. The study...
2020-12-23 19:53
1648
Innovent Announces NMPA Granted New Indication Approvals for SULINNO® (Adalimumab Injection) for the Treatment of Pediatric Plaque Psoriasis and Non-infectious Uveitis
SAN FRANCISCO and SUZHOU, China, Dec. 23, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2020-12-23 12:30
8820
RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue
Independent DSMB unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 based on review of unblinded safety data from 155 treated patients Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021 Top-line d...
2020-12-22 20:38
4540
Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announces today dosing of overweight and obese subjects in a Phase Ib trial of ASC41, an oral tablet,...
2020-12-22 19:18
3050
Leapstack has completed tens of millions of yuan in B plus round fundraising, expending intelligent risk control territory
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- Leapstack, an insur-tech company, has recently announcedtens of millions of yuan B plus round fundraising, leading by Huazhi Capital, a venture capitalist affiliated toAllinpay Network Services, and following by GF Securities Investment. In the past few ye...
2020-12-22 15:50
4701
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004
SEATTLE, Dec. 21, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced its partnership with Laboratoire Pierre Fabre to manufacture ER-004 – an intra-amniotic drug that will pioneer the treatment of a rare and...
2020-12-21 23:00
2874
Servier to Acquire Agios Pharmaceuticals' Oncology Business
- Transaction includes commercial, clinical and research-stage oncology portfolio and employees for up to$2 billion plus royalties - Includes Agios' marketed medicine TIBSOVO® and a strong oncology pipeline of Phase 3 and early-stage assets - Acquisition in-line with Servier's strategic ambition...
2020-12-21 22:26
1828
LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA
TAIPEI, Dec. 21, 2020 /PRNewswire/ -- Lumosa Therapeutics is pleased to announce the market approval of LT1001 (Naldebain®), an extended-release analgesic injection, fromSingapore's Health Science Agency (HSA). HSA is regarded as one of the regulatory reference countries in the world. The approv...
2020-12-21 22:08
1995
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens
VANCOUVER, British Columbia, Dec. 21, 2020 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTC:LMNGF) ("BioVaxys") announced today that further analysis of the data from a preclinical animal study (also known as the "murine model study") of its haptenized viral protein vaccine tech...
2020-12-21 21:00
2410
Neusoft Medical has reached a strategic cooperation of Sino-Pakistan Healthcare in Pakistan
SHENYANG, China, Dec. 21, 2020 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. (Neusoft Medical) announced the cloud signing of a memorandum of understanding (MOU) with Dynamic Engineering and Automation Group (DEA) to cooperate in the area of healthcare inPakistan. The partnership intends to ...
2020-12-21 19:18
1686
Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
SHANGHAI and HONG KONG, Dec. 21, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) submitted by its partner Karyopharm Therapeutics Inc. (Nasdaq...
2020-12-21 08:00
3948
Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation
SCHAFFHAUSEN, Switzerland, Dec. 18, 2020 /PRNewswire/ -- Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for Pulmonary Art...
2020-12-18 21:29
4240
Antengene Announces Approval of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM
SHANGHAI and HONG KONG, Dec.18, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncolo...
2020-12-18 15:34
5590
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals
* Research on preventative COVID-19 nasal spray published in prestigious, peer-reviewed academic journals: EBioMedicine and the European Respiratory Journal * Novel therapy developed by Australian biotech company, Ena Respiratory, shown in animal study to reduce COVID-19 virus levels in the n...
2020-12-18 06:52
1881
Small vessels can cause big problems; MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions
TAMPA, Fla., Dec. 18, 2020 /PRNewswire/ -- Concept Medical Inc.
2020-12-18 03:16
3339
Tessa Therapeutics Appoints David McIntyre as Chief Financial Officer
BEDMINSTER, N.J. and SINGAPORE, Dec. 17, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced the appointment ofDavid McIntyre as its Chief Financial Officer. Mr. McIntyre brings over 25 years of glo...
2020-12-17 22:32
2802
Hoppen Commended by Frost & Sullivan for Improving Patient Experience with its Best-in-Class Infotainment Solutions for Smart Hospitals
Hoppen supports healthcare facilities by using digital tools to improve patient services, facilitate internal processes, and optimize the staff's daily tasks LONDON, Dec. 17, 2020 /PRNewswire/ -- Based on its recent analysis of the global advanced infotainment systems market for smart hospitals, ...
2020-12-17 22:15
2159
Deep Longevity Publishes the First Human Psychological Aging Clock Using Artificial Intelligence
HONG KONG, Dec. 17, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK: 0575.HK)'s Deep Longevity, Inc, a company developing artificial intelligence to track human aging and extend productive longevity, releas...
2020-12-17 20:08
10834
Seegene donates 20,000 COVID-19 tests to Ecuador
SEOUL, South Korea, Dec. 17, 2020 /PRNewswire/ -- Seegene Inc. (KQ096530), a South Korean biotechnology company specializing in molecular diagnostics says it has donated 20,000 COVID-19 tests (Allplex™ SARS-CoV-2 Assay) to Ecuadorian government to help fight the COVID-19 pandemic together. The So...
2020-12-17 15:24
2076
dMed Completed a US$100 Million Series C Financing
SHANGHAI, Dec. 17, 2020 /PRNewswire/ -- dMed, the clinical CRO with strong presence inChina and the US, the world's two largest pharmaceutical markets and drug development sites, announced today its successful completion of aUS$100 million Series C financing. Led by Fidelity Management & Research...
2020-12-17 13:00
2783
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8288
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7685